Naperville, IL -- (SBWIRE) -- 06/29/2012 -- Portugal Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018 a new report provides key market data on the Portugal Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Nephrology and Urology Devices market size and company share data for market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Portugal Nephrology and Urology Devices market.
- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Fresenius Medical Care AG & Co. KGaA, Gambro AB, HARTMANN GROUP, Baxter International Inc., ONTEX International N.V. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Portugal Nephrology and Urology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

Svenska Cellulosa Aktiebolaget SCA Fresenius Medical Care AG & Co. KGaA Gambro AB HARTMANN GROUP ONTEX International N.V. Baxter International Inc. B. Braun Melsungen AG Coloplast A/S First Quality Enterprises, Inc. Astra Tech Inc. Kimberly-Clark Corporation Covidien plc Siemens Healthcare Medline Industries, Inc. Dornier MedTech GmbH

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67566/portugal-nephrology-and-urology-devices-investment-opportunities-analysis-and-forecasts-to-2018.html

...

Naperville, IL -- (SBWIRE) -- 06/29/2012 -- Poland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018 a new report provides key market data on the Poland Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Nephrology and Urology Devices market market size and company share data for categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Poland Nephrology and Urology Devices market.
- Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Baxter International Inc., Svenska Cellulosa Aktiebolaget SCA, HARTMANN GROUP, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Poland Nephrology and Urology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

Fresenius Medical Care AG & Co. KGaA Gambro AB Baxter International Inc. Svenska Cellulosa Aktiebolaget SCA HARTMANN GROUP B. Braun Melsungen AG ONTEX International N.V. First Quality Enterprises, Inc. Coloplast A/S Astra Tech Inc. Kimberly-Clark Corporation NIPRO CORPORATION Covidien plc Dornier MedTech GmbH STORZ MEDICAL AG Abena A/S Medline Industries, Inc. Siemens Healthcare

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67565/poland-nephrology-and-urology-devices-investment-opportunities-analysis-and-forecasts-to-2018.html

...

Naperville, IL -- (SBWIRE) -- 06/29/2012 -- Ireland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018 a new report by provides key market data on the Ireland Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Nephrology and Urology Devices market size and company share data for market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Ireland Nephrology and Urology Devices market.
- Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., HARTMANN GROUP, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Ireland Nephrology and Urology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

Fresenius Medical Care AG & Co. KGaA Gambro AB Svenska Cellulosa Aktiebolaget SCA Baxter International Inc. HARTMANN GROUP B. Braun Melsungen AG ONTEX International N.V. Coloplast A/S First Quality Enterprises, Inc. Kimberly-Clark Corporation Teleflex Incorporated Covidien plc Dornier MedTech GmbH STORZ MEDICAL AG Medline Industries, Inc. Siemens Healthcare

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67562/ireland-nephrology-and-urology-devices-investment-opportunities-analysis-and-forecasts-to-2018.html

...

NEWS-SUN STAFF REPORT June 29, 2012 3:58PM

• Reprints

Updated: June 30, 2012 2:16AM

WAUKEGAN — Fresenius Medical Care’s Waukegan Harbor dialysis center has opened just west of the city’s downtown at 110 N. West St.

Officials with Fresenius Medical Care North America, headquartered in Waltham, Mass., said the 21-station clinic will provide treatment to the region’s growing population of patients with chronic kidney disease.

Dialysis is a process that cleans waste products from the blood, removes extra fluids and controls the body’s chemistry when a person’s kidneys fail. Dialysis patients usually require treatment on an ongoing basis unless they receive a kidney transplant.

“Patients typically receive dialysis three times a week for four hours each session. Given the frequency and duration of treatment, we do all we can to ensure our patients’ comfort and help them integrate their appointments into their daily lives,” said Mercy Saavedra, R.N., clinical manager for Fresenius Medical Care.”

Dr. Rakhi Khanna, a nephrologist with North Suburban Nephrology in Gurnee, serves as medical director at the new Medicare-certified facility. Fresenius is the nation’s leading network of dialysis facilities,

“The reaction from the Waukegan community has been wonderful,” said Dr. Khanna. “Our patients — some of whom previously had to travel as far as Antioch for treatment — were happy to see us open our doors.”

The Fresenius clinic offers patients a full range of dialysis-related medical services including a kidney transplant support program, nutrition counseling, bone disease management and social worker support. The facility also features technology, such as touch-screen dialysis station monitors that allow clinical staff to enter and securely track patient information.

...